WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

VALIDATED BCS COMPARATIVE DISSOLUTION METHOD FOR HYDROCHLOROTHIAZIDE TABLETS

Jenaé Van Wyk, Joe M. Viljoen and Marius Brits*

ABSTRACT

Hydrochlorothiazide (HCTZ) is a globally used thiazide diuretic forthe treatment of hypertension and edema. It has been classified as aClass I/III drug according to the biopharmaceutical classificationsystem (BCS), thus potentially qualifying for BCS based biowaiverdissolution studies, waiving the regulatory requirement for in vivobioavailability (BA) and/or bioequivalence (BE) studies whendeveloping a generic immediate release solid oral dosage form.Regulatory guidelines require the use of validated analyticalprocedures during the performance of such comparative dissolutionstudies. A review of the available literature indicated that no validatedanalytical method has thus far been published for the quantification ofHCTZ release from conventional immediate release tablets during BCSbased biowaiver dissolution studies. Therefore, the aim of this studywas to develop and validate an analytical method for BCS comparativedissolution testing in accordance with the WHO and ICH guidelinesfor HCTZ. The developed and validated UV/Vis method quantifies the release of HCTZ at271 nm in the three biorelevant dissolution media. The method revealed acceptable accuracyraging between 99–101% over a linear working range of 1.4–17.0 μg/mL. Using method ofstandard addition the absence of excipient interferences was illustrated. The limit of detectionand quantification limit of the method were found to range between 0.120–0.350 μg/mL and0.364–1.061 μg/mL respectively. The stability of analytical solutions under normal analyticalconditions and the suitability of the filter-material were investigated and reported. Thisanalytical method will thus support generic medicine manufacturers and medicines regulatory authorities in their respective mandates, to ensure the availability of safe and efficaciousmedicines to the public.

Keywords: Hydrochlorothiazide, analytical method, validation, drug dissolution, spectrophotometry.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More